JPRN-UMIN000008971已完成未知
Safety and Efficacy analysis of 10 mg donepezil for severe Alzheimer's disease: switch from the other cholineseterase inhibitors - Switch to 10 mg donepezil for severe Alzheimer's disease
epartment of Neurology, Juntendo University School of Medicine0 个研究点目标入组 50 人开始时间: 2012年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
Sufficient number of subjects did not complete this study because people with severe dementia stopped to visit the hospital.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients with dementia except AD 2.Patients with high serum Vitamine level 3.Patients who are allergic to donepezil
研究者
相似试验
已完成
4 期
Donepezil to Treat Dementia in Parkinson's DiseaseParkinson DiseaseNCT00030979National Institute of Neurological Disorders and Stroke (NINDS)28
已完成
不适用
Efficacy of donepezil in Alzheimer's disease combined with cerebrovascular diseases diseaseAlzheimer's diseaseJPRN-UMIN000010408Department of Neurology, Keio University,460
Unknown
4 期
A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in SchizophreniaImpaired CognitionSchizophreniaNCT01490567Central South University80
已完成
4 期
The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)Memory LossNCT00293176Eisai Inc.821
已完成
不适用
A study on usefulness and safety of donepezil for cognitive function and phychological symptoms of patients with Parkinson's disease and Alzheimer type dementia.s diseaseParkinson's diseaseJPRN-UMIN000010752Kansai Medical University50